PharmaTalkRadio

Podcast on Mobile in Clinical Trials Series #1

How a Mobile App Can Offer Unique Value in Assessing Patient Reported Outcomes

Crescendo Biosciences's CIO, Alex Bangs, reports on how a human-centered design approach was used to create MyRA, an award-winning app for patients living with RA. This podcast comes from the 2017 Mobile in Clinical Trials US event. 

The next Mobile in Clinical Trials conference is May 15-16 in London and then September 24 in Boston. Mobile is the annual update on not only the latest progress in applying mobile/digital tools to clinical trials, but how and when to do this and for what benefit. 

Speaker: Alex Bangs, Chief Information Officer, Crescendo Biosciences

Producer: Kim Chin, Marketing Director, Mobile in Clinical Trials

The Chief Medical Officer Summit is delighted to present a podcast featuring the Keynote Fireside Chat with Michael Rosenblatt, MD, on Lessons Learned from the Journey of a CMO Leader

In this session, Dr Rosenblatt, former Merck CMO, will share his insights on career path decision-making and will compare the experiences and lessons learned from being the CMO on the drug development side versus the biotech investor side of the industry. Moderated by CEO of Evelo Biosciences, Simba Gill, MBA, PhD. 

Join us at the 6th annual CMO Summit, the largest annual gathering for physicians to exchange best practices in clinical development within the confines of the emerging biotech space. We already have 50 CMOs confirmed to attend. You won't want to miss out on this event.

Producer: Valerie Bowling, Executive Director, Chief Medical Officer Summit

The Chief Medical Officer Summit is delighted to share a podcast featuring a presentation prepared by Drs Alison Bateman-House and Arthur Caplan of NYU's Division of Medical Ethics on the topic of:  

Developing a Pathway for Compassionate Use Cases

What should the CMO do when they receive a request?What's the role of the CMO, the FDA and the IRB?Lessons learned from Janssen Case StudyHow do you scale down for a biotech?Potential modelsCan the process be accelerated?

Join us at the 6th annual Chief Medical Officer Summit, the largest annual gathering for physicians to exchange best practices in clinical development and R&D within in the confines of the emerging biotech space. We already have 50 CMOs confirmed to attend, and you will not want to miss out on this event.

Speaker: Alison Bateman-House, PhD, MPH,Assistant Professor, Division of Medical Ethics,NYU

Producer: Valerie Bowling, Executive Director, Chief Medical Officer Summit

This podcasts gives you an overview on what to expect for the 2018 Chief Medical Officer Summit in a nutshell. The concept of the CMO Summit came from MPM Capital’s Dr Elizabeth Stoner, who told us that there is a deep need for a Summit that is designed for CMOs and heads of R&D in the emerging biotech space, specifically, where we can cover all the key issues affecting R&D decisions together with business development issues. The program takes place on May 7th and 8th at the Omni Parker House in Boston and we already have over 50 CMOs committed to attending.

The program is co-chaired by Julie Krop, MD, CMO, EVP, Clinical Development & Regulatory Affairs, AMAG Pharmaceuticals, Inc,  and Jim Roach, MD, FACP, FCCP, CMO, Pulmatrix.

The 6th Annual Chief Medical Officer Summit is produced by the Conference Forum. The Conference Forum is life science industry research firm that carefully and meticulously presents strategic level programming. As with all Conference Forum events, you can expect prominent networking. To learn more about the event, visit www.theconferenceforum.org. Be sure to use code TEML for a 10% discount. Thanks for listening.

In this three minute podcast, you get an overview of one of the hottest topics we are covering in a full day 2nd annual event on Clinical Research as a Care Option. (CRAACO). Making clinical trials a care option is arguably the greatest challenge we can collaborate on in bringing patients closer to clinical trials. CRAACO takes place on April 11th at the Boston Marriott Cambridge. We look at how to integrate clinical research into the overall continuum of patient care and ask, how do we make clinical research a care option?

The program is co-chaired by Jeff James CEO, Wilmington Health and Katherine Vandebelt, Chief Ecosystem Officer at Reify Health.

The 2nd annual CRAACO event is produced by the Conference Forum. The Conference Forum is life science industry research firm with veteran researchers, who carefully and meticulously present strategic level programming. As with all Conference Forum events, you can expect networking activities and prominent networking. To learn more about CRAACO, visit www.theconferenceforum.org. Be sure to use code TEML for a 10% discount. Thanks for listening.

This podcast gives you a five minute overview of the 3rd annual Clinical Trial Collaborations conference, otherwise known as CTC.

CTC is a strategic level event focused on arguably the most important change in transforming drug development: How and who we collaborate with to drive better clinical trial outcomes?

CTC is ideal for people working in clinical trial operations, who are involved with external relationships or need to be involved with external relationships and want to see examples of strategic and creative solutions to successful collaborations and who we need to be collaborating with next?

The program takes place on April 9th – 11th at the Boston Marriott Cambridge and is divided into three parts, one on each day of the event. Part I deals with new advancements in clinical trial collaborations, current examples to challenge us, and progress. Part II focuses on strategic collaborations, virtual trials and next generation monitoring. Part III addresses how do we bring clinical research closer to patients and vice versa.

CTC is co-chaired by Ken Getz, Director of Sponsored Research, Tufts CSDD, Murray Abramson, MD, VP, Clinical Operations, Biogen, Jeff James, CEO, Wilmington Health and Katherine Vandebelt, Chief Ecosystem Officer, Reify Health.

Use code TEML for 10% off and for more information visit, www.theconferenceforum.org.

The Mobile in Clinical Trials conference comes to Europe for the first time on May 15th and 16th at the Millennium Gloucester Hotel in London. If you work or want to work with mobile and digital technologies to make clinical trials more efficient and reduce patient burden, we highly recommend this conference for you. Using our past four years of experience in the US, we are able to combine the best examples of mobile and digital optimization in clinical trials from the US with examples from the UK and other parts of Europe.

Mobile in Clinical Trials Europe is chaired by Pfizer’sDr Daniel Karlin with a pharma speaking faculty of who’s who in leading mobile in clinical trials. VIP Guests include Verily Life Sciences’Dr Tushar Parlikar on how Verily’s studywatch is tackling scalability of wearables in clinical trials and Vodafone’s Dr Nuria Oliver, who gives a visionary keynote to address data-driven decision making.

Mobile in Clinical Trials Europe is produced by the Conference Forum. The Conference Forum is life science industry research firm with veteran researchers, who carefully and meticulously present high quality programming. As with all Conference Forum events, you can expect networking activities and prominent networking.

To learn more, visit www.theconferenceforum.org. Be sure to use code TEML for a 10% discount. Thanks for listening.

Dr Roslyn Schneider, Global Patient Affairs Lead at Pfizer, speaks with Valerie Bowling, Executive Director, Patients as Partners, in a podcast interview on patients at the center of clinical research. Dr Schneider, better known as Roz, helps drive patient centricity and the integration of the patiemt voice throughout the development of medicines at Pfizer. She gives us a brief history of the evolution of the involvement of patients in clinical research, next steps, and how patients and industry can collaborate.

Roz, together with Suzanne Schrandt, Director of Patient Engagement at the Arthritis Foundation, will co-chair the 5th annual Patients as Partners conference, March 15-16 at the Rittenhouse Hotel in Philadelphia. For more information, visit theconferenceforum.org.

DPharm Podcast Series #5

Reducing the Burden of Type 1 Diabetes through a Model of Democratized R&D

Patient advocate star, Dana Lewis, founder of OpenAPS delivers a powerful session at DPharm on an idea to reduce the burden of type 1 diabetes with a smart system she created through open soucre. Learn how she drive the idea and creation of the "Self driving car for diabetes".

The next DPharm conference is September 25-26 in Boston. DPharm reports on innovation and disruptive innovation to advance clinical trials and supports the community behind the movement.

Speaker: Dana Lewis, Creator, Do-It-Yourself Pancreas System and Founder, OpenAPS

Producer: Valerie Bowling, Executive Director, DPharm

5th Annual Patients as Partners What to Expect Overview Podcast

Officially approved by Patients Included, Patients as Partners is the only program in the US that truly demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. Taking place March 15-16 in Philadelphia, the focus of this year’s program is on turning discussion into action, and Kate Woda, the Conference Director has worked meticulously with the advisory board and members of the speaking faculty both in person and over the phone to make this happen. Valerie Bowling, Executive Director of the Conference Forum gives listeners an overview in a nutshell on what to expect.

Co Chairs:

Roslyn Schneider, MD

Global Patient Affairs Lead, Pfizer Medical

Suzanne Schrandt, JD (Newly confirmed!)

Director, Patient Engagement, Arthritis Foundation

Patient Keynote: Stefanie Joho, Cancer Survivor, Advocate and Consultant

For more information, visit www.theconferenceforum.org